☆ 4.7 Letter

Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies

JOURNAL OF INFECTION (2021)

Journal

JOURNAL OF INFECTION

Volume 83, Issue 2, Pages 239-241

Publisher

W B SAUNDERS CO LTD

DOI: 10.1016/j.jinf.2021.05.024

Keywords

-

Categories

Infectious Diseases

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Cell Biology

Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants

Abishek Chandrashekar, Jinyan Liu, Jingyou Yu, Katherine McMahan, Lisa H. Tostanoski, Catherine Jacob-Dolan, Noe B. Mercado, Tochi Anioke, Aiquan Chang, Sarah Gardner, Victoria M. Giffin, David L. Hope, Felix Nampanya, Shivani Patel, Owen Sanborn, Daniel Sellers, Huahua Wan, Amanda J. Martinot, John J. Baczenas, Shelby L. O'Connor, Laurent Pessaint, Daniel Valentin, Benjamin Espina, Lauren Wattay, Maria G. Ferrari, Renita Brown, Anthony Cook, Deandre Bueno-Wilkerson, Elyse Teow, Hanne Andersen, Mark G. Lewis, Dan H. Barouch

Summary: Natural immunity induced by the original SARS-CoV-2 WA1/2020 strain provides partial but incomplete protection against the B.1.1.7 (alpha) and B.1.351 (beta) variants. Further research is needed to understand the implications for vaccination and public health strategies in the face of emerging SARS-CoV-2 variants of concern.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Review Immunology

Reinfections in COVID-19 Patients: Impact of Virus Genetic Variability and Host Immunity

Aisha Fakhroo, Hebah A. AlKhatib, Asmaa A. Al Thani, Hadi M. Yassine

Summary: The COVID-19 pandemic continues to pose a devastating threat to social life and economics, with the rise in active cases attributed to the emergence of new SARS-CoV-2 variants. While reinfection cases worldwide have been limited, most reinfected patients were asymptomatic, and the reasons for reinfection included immunological factors. Vaccines have shown effectiveness in preventing severe illness from different variants.

VACCINES (2021)

Add to Collection

Article Cell Biology

IgG targeting distinct seasonal coronavirus-conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes

Jose L. Garrido, Matias A. Medina, Felipe Bravo, Sarah McGee, Francisco Fuentes-Villalobos, Mario Calvo, Yazmin Pinos, James W. Bowman, Christopher D. Bahl, Maria Ines Barria, Rebecca A. Brachman, Raymond A. Alvarez

Summary: A study found that disease severity in COVID-19 patients is positively correlated with levels of anti-spike IgG, cross-reactivity with other coronaviruses, and activation of Fc gamma receptors. Furthermore, specific regions within the SARS-CoV-2 spike protein targeted by IgG were associated with disease severity, particularly the conserved heptad repeat (HR) 2 region.

CELL REPORTS (2022)

Add to Collection

Article Multidisciplinary Sciences

A prenylated dsRNA sensor protects against severe COVID-19

Arthur Wickenhagen, Elena Sugrue, Spyros Lytras, Srikeerthana Kuchi, Marko Noerenberg, Matthew L. Turnbull, Colin Loney, Vanessa Herder, Jay Allan, Innes Jarmson, Natalia Cameron-Ruiz, Margus Varjak, Rute M. Pinto, Jeffrey Y. Lee, Louisa Iselin, Natasha Palmalux, Douglas G. Stewart, Simon Swingler, Edward J. D. Greenwood, Thomas W. M. Crozier, Quan Gu, Emma L. Davies, Sara Clohisey, Bo Wang, Fabio Trindade Maranhao Costa, Monique Freire Santana, Luiz Carlos de Lima Ferreira, Lee Murphy, Angie Fawkes, Alison Meynert, Graeme Grimes, Joao Luiz Da Silva Filho, Matthias Marti, Joseph Hughes, Richard J. Stanton, Eddie C. Y. Wang, Antonia Ho, Ilan Davis, Ruth F. Jarrett, Alfredo Castello, David L. Robertson, Malcolm G. Semple, Peter J. M. Openshaw, Massimo Palmarini, Paul J. Lehner, J. Kenneth Baillie, Suzannah J. Rihn, Sam J. Wilson

Summary: Inherited genetic factors can influence the severity of COVID-19, with intracellular antiviral defenses, particularly OAS1 through ribonuclease L, playing a significant role in inhibiting SARS-CoV-2. The expression of prenylated OAS1 may be associated with protection from severe COVID-19 in hospitalized patients.

SCIENCE (2021)

Add to Collection

Article Medicine, General & Internal

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection

Victoria Hall, Sarah Foulkes, Ferdinando Insalata, Peter Kirwan, Ayoub Saei, Ana Atti, Edgar Wellington, Jameel Khawam, Katie Munro, Michelle Cole, Caio Tranquillini, Andrew Taylor-Kerr, Nipunadi Hettiarachchi, Davina Calbraith, Noshin Sajedi, Iain Milligan, Yrene Themistocleous, Diane Corrigan, Lisa Cromey, Lesley Price, Sally Stewart, Elen de Lacy, Chris Norman, Ezra Linley, Ashley D. Otter, Amanda Semper, Jacqueline Hewson, Silvia D'Arcangelo, Meera Chand, Colin S. Brown, Tim Brooks, Jasmin Islam, Andre Charlett, Susan Hopkins

Summary: This study investigated the duration and effectiveness of immunity among healthcare workers in the United Kingdom. It found that two doses of the BNT162b2 vaccine provided high short-term protection against SARS-CoV-2 infection, but this protection significantly decreased after six months. However, infection-acquired immunity boosted by vaccination remained high, even more than one year after infection.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Infectious Diseases

Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers

Leticia Adrielle dos Santos, Pedro Germano de Gois Filho, Ana Maria Fantini Silva, Joao Victor Gomes Santos, Douglas Siqueira Santos, Marilia Marques Aquino, Rafaela Mota de Jesus, Maria Luiza Doria Almeida, Joao Santana da Silva, Daniel M. Altmann, Rosemary J. Boyton, Cliomar Alves dos Santos, Camilla Natalia Oliveira Santos, Juliana Cardoso Alves, Ianaline Lima Santos, Lucas Sousa Magalhaes, Emilia M. M. A. Belitardo, Danilo J. P. G. Rocha, Joao P. P. Almeida, Luis G. C. Pacheco, Eric R. G. R. Aguiar, Gubio Soares Campos, Silvia Ines Sardi, Rejane Hughes Carvalho, Amelia Ribeiro de Jesus, Karla Freire Rezende, Roque Pacheco de Almeida

Summary: This study presents 33 cases of recurrent COVID-19, with most cases being healthcare workers and blood type A. The average time to recurrence was 50.5 days, and recurrent patients had significantly lower SARS-CoV-2 antibodies in their system.

JOURNAL OF INFECTION (2021)

Add to Collection

Article Immunology

Immune response variables and viral mutations impact on COVID-19 reinfection and relapse

Sarvin Sanaie, Elham Golipour, Ali Shamekh, Mohammad Reza Sadaie, Ata Mahmoodpoor, Mehdi Yousefi

Summary: The potential for human reinfection with SARS-CoV-2 remains uncertain despite the presence of antibodies and immune cells, as the virus can mutate and affect its spread. Both innate and adaptive immune responses in individuals play a crucial role in the dynamics of virus infection.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories

Yong Ge, Wen-Bin Zhang, Xilin Wu, Corrine W. Ruktanonchai, Haiyan Liu, Jianghao Wang, Yongze Song, Mengxiao Liu, Wei Yan, Juan Yang, Eimear Cleary, Sarchil H. Qader, Fatumah Atuhaire, Nick W. Ruktanonchai, Andrew J. Tatem, Shengjie Lai

Summary: Non-pharmaceutical interventions (NPIs) and COVID-19 vaccination have been implemented concurrently, making their relative effects difficult to measure. Here, the authors show that effects of NPIs reduced as vaccine coverage increased, but that NPIs could still be important in the context of more transmissible variants.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Medicine, Research & Experimental

Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19

Alec A. Schmaier, Gabriel M. Pajares Hurtado, Zachary J. Manickas-Hill, Kelsey D. Sack, Siyu M. Chen, Victoria Bhambhani, Juweria Quadir, Anjali K. Nath, Ai-Ris Y. Collier, Debby Ngo, Dan H. Barouch, Nathan Shapiro, Robert E. Gerszten, Xu G. Yu, Kevin G. Peters, Robert Flaumenhaft, Samir M. Parikh

Summary: Endothelial dysfunction and changes in the Tie2/angiopoietin axis are associated with severe COVID-19, leading to a procoagulant state and potential harm to lung tissues. Primary endothelial cells treated with COVID-19 plasma exhibited a prothrombotic state, which was reversed by activation of Tie2 with AKB-9778.

JCI INSIGHT (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic

Rehan M. El-Shabasy, Mohamed A. Nayel, Mohamed M. Taher, Rehab Abdelmonem, Kamel R. Shoueir, El Rafaie Kenawy

Summary: It has been over a year since the first case of COVID-19 was reported in China. The world has witnessed three waves of the virus, with varying characteristics and challenges. Despite a decrease in the sense of danger in most countries, the emergence of new variant strains has raised concerns again. The mutations in COVID-19 have presented an extreme challenge in preventing and treating the virus, and there are still many unanswered questions about the effectiveness of vaccines and the need for annual doses.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Add to Collection

Article Multidisciplinary Sciences

COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants

Pinja Jalkanen, Pekka Kolehmainen, Hanni K. Hakkinen, Moona Huttunen, Paula A. Tahtinen, Rickard Lundberg, Sari Maljanen, Arttu Reinholm, Sisko Tauriainen, Sari H. Pakkanen, Iris Levonen, Arttu Nousiainen, Taru Miller, Hanna Valimaa, Lauri Ivaska, Arja Pasternack, Rauno Naves, Olli Ritvos, Pamela Osterlund, Suvi Kuivanen, Teemu Smura, Jussi Hepojoki, Olli Vapalahti, Johanna Lempainen, Laura Kakkola, Anu Kantele, Ilkka Julkunen

Summary: The study shows that the second dose of the BNT162b2 vaccine can induce cross-neutralization to some extent of SARS-CoV-2 variants, providing partial protection. Despite the reduced neutralization effect on the B.1.351 variant, the majority of vaccinees still have some level of protection.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia

Ludek Berec, Martin Smid, Lenka Pribylova, Ondrej Majek, Tomas Pavlik, Jiri Jarkovsky, Milan Zajicek, Jakub Weiner, Tamara Barusova, Jan Trnka

Summary: Studies in Czech Republic show that the effectiveness of COVID-19 vaccines declines after 7-8 months, with a decrease in protection against infection, hospitalization, and death. Boosters are found to restore the original vaccine effectiveness, and post-infection immunity also diminishes over time.

PLOS ONE (2022)

Add to Collection

Article Immunology

Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection

Purwa Doke, Jayshree Sachin Gothankar, Prakash Prabhakarrao Doke, Milind Madhukar Kulkarni, Kiran Kishanrao Khalate, Shubham Shrivastava, Jayesh Rangrao Patil, Vidya Avinash Arankalle

Summary: The study aims to assess the modulation of neutralizing antibody titers in COVID-19 patients and understand the association with variables such as age, comorbidity, BMI, and gender. The results show a significant reduction in neutralizing antibody titers over time and their correlation with age, disease severity, comorbidity, BMI, and gender.

MICROBES AND INFECTION (2022)

Add to Collection

Article Medicine, Research & Experimental

COVID-19 diverse outcomes: Aggravated reinfection, type I interferons and antibodies

Rafael Cardoso Maciel Costa Silva, Christianne Bandeira-Melo, Heitor Afonso Paula Neto, Andre Macedo Vale, Leonardo Holanda Travassos

Summary: This article discusses potential mechanisms of SARS-CoV-2 reinfections, including severe reinfections. The major topics include the imbalance between interferon and antibody responses, HLA heterogeneity among affected individuals, and the increased proportion of cytotoxic CD4+ T cell polarization related to T follicular cell subtypes. These features affect antibody levels and impair the humoral immunity necessary to prevent or minimize viral burden in reinfections.

MEDICAL HYPOTHESES (2022)

Add to Collection

Article Medicine, General & Internal

Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19

Ariel Hammerman, Ruslan Sergienko, Michael Friger, Tanya Beckenstein, Alon Peretz, Doron Netzer, Shlomit Yaron, Ronen Arbel

Summary: This retrospective cohort study in Israel found that receiving at least one dose of the BNT162b2 vaccine was associated with a significantly lower risk of recurrent infection among patients who had recovered from Covid-19. Vaccine effectiveness was similar for one dose and two doses.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Infectious Diseases

Impact of rapid susceptibility testing on antimicrobial therapy and clinical outcomes in Gram-negative bloodstream infections

Vanesa Anton-Vazquez, Cristina Suarez, Timothy Planche

Summary: This study evaluated the impact of rapid antimicrobial susceptibility testing on antimicrobial therapy and clinical outcomes in patients with Gram-negative bloodstream infection. The results showed that rapid susceptibility testing led to faster discontinuation of aminoglycosides and a shorter time to starting effective and optimal antibiotic therapy.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Add to Collection

Article Infectious Diseases

Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies

Sophie Owen, Christopher T. Williams, Gala Garrod, Alice J. Fraser, Stefanie Menzies, Lisa Baldwin, Lottie Brown, Rachel L. Byrne, Andrea M. Collins, Ana Cubas-Atienzar, Margaretha de Vos, Thomas Edwards, Camille Escadafal, Daniela M. Ferreira, Tom Fletcher, Angela Hyder-Wright, Grant A. Kay, Konstantina Kontogianni, Jenifer Mason, Elena Mitsi, Tim Planche, Jilian A. Sacks, Joseph Taylor, Stacy Todd, Caroline Tully, Luis E. Cuevas, Emily R. Adams

Summary: The evaluation of 12 LFAs showed varying sensitivity and specificity, with improved sensitivity for IgM/IgG over time since symptom onset. Compared to the EuroImmun IgG ELISA, LFAs exhibited different levels of sensitivity and specificity.

JOURNAL OF INFECTION (2022)

Add to Collection

Article Urology & Nephrology

Sickle Cell Trait and Kidney Disease in People of African Ancestry With HIV

Rachel K. Y. Hung, Elizabeth Binns-Roemer, John W. Booth, Rachel Hilton, Julie Fox, Fiona Burns, Mark Harber, Andrew Ustianowski, Lisa Hamzah, James E. Burns, Amanda Clarke, David A. Price, Stephen Kegg, Denis Onyango, Beatriz Santana-Suarez, Lucy Campbell, Kate Bramham, Claire C. Sharpe, Caroline A. Sabin, Cheryl A. Winkler, Frank A. Post

Summary: This study investigated the association between sickle cell trait (SCT) and kidney disease in people of African ancestry with HIV in the UK. The results showed that individuals with SCT were more likely to have lower glomerular filtration rate, proteinuria, and albuminuria. These associations were particularly significant in participants with low-risk APOL1 genotypes.

KIDNEY INTERNATIONAL REPORTS (2022)

Add to Collection

Article Infectious Diseases

T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study

Adrienn Angyal, Stephanie Longet, Shona C. Moore, Rebecca P. Payne, Adam Harding, Tom Tipton, Patpong Rongkard, Mohammad Ali, Luisa M. Hering, Naomi Meardon, James Austin, Rebecca Brown, Donal Skelly, Natalie Gillson, Sue L. Dobson, Andrew Cross, Gurjinder Sandhar, Jonathan A. Kilby, Jessica K. Tyerman, Alexander R. Nicols, Jarmila S. Spegarova, Hema Mehta, Hailey Hornsby, Rachel Whitham, Christopher P. Conlon, Katie Jeffery, Philip Goulder, John Frater, Christina Dold, Matthew Pace, Ane Ogbe, Helen Brown, M. Azim Ansari, Emily Adland, Anthony Brown, Meera Chand, Adrian Shields, Philippa C. Matthews, Susan Hopkins, Victoria Hall, William James, Sarah L. Rowland-Jones, Paul Klenerman, Susanna Dunachie, Alex Richter, Christopher J. A. Duncan, Eleanor Barnes, Miles Carroll, Lance Turtle, Thushan de Silva

Summary: This study compares immune responses to the BNT162b2 mRNA vaccine in healthcare workers with and without previous SARS-CoV-2 infection. The results show that previously infected individuals have stronger spike-specific T-cell and antibody responses after receiving a single dose of the vaccine compared to SARS-CoV-2-naive individuals. This suggests that a single dose of the BNT162b2 vaccine is likely to provide better protection against SARS-CoV-2 infection in individuals with previous infection.

LANCET MICROBE (2022)

Add to Collection

Letter Immunology

Renal mitochondrial toxicity: effects of thymidine analogues and tenofovir disoproxil fumarate in African people with HIV

Matthew Hunt, Richard Phillips, Yasmine Hardy, Dorcas O. Owusu, Rosa Mitchelmore, Mehrab Durrani, Brendan A. I. Payne, David R. Chadwick

Summary: This study investigated the effects of thymidine analogue and TDF antiretroviral therapy on renal mitochondrial toxicity in Ghanaian people with HIV (PWH). Similar levels of renal biochemical and mitochondrial dysfunction were observed, and there was no increased risk in PWH who switched from thymidine analogue to TDF. However, mild renal impairment was associated with mitochondrial DNA damage in TDF-treated PWH but not in those treated with thymidine analogue. These findings support the continued use of TDF in resource-limited settings.

AIDS (2022)

Add to Collection

Article Immunology

Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naive and convalescent healthcare workers

Eloise Phillips, Sandra Adele, Tom Malone, Alexandra Deeks, Lizzie Stafford, Susan L. Dobson, Ali Amini, Donal Skelly, David Eyre, Katie Jeffery, Christopher P. Conlon, Christina Dold, Ashley Otter, Silvia D'Arcangelo, Lance Turtle, Paul Klenerman, Eleanor Barnes, Susanna J. Dunachie

Summary: Two different experimental methods were used to detect T-cell responses to SARS-CoV-2, and it was found that the commercially available OI T-SPOT method reported significantly lower responses compared to the PITCH ELISpot method.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2022)

Add to Collection

Article Infectious Diseases

Clinical features and management of human monkeypox: a retrospective observational study in the UK

Hugh Adler, Susan Gould, Paul Hine, Luke B. Snell, Waison Wong, Catherine F. Houlihan, Jane C. Osborne, Tommy Rampling, Mike Bj Beadsworth, Christopher Ja Duncan, Jake Dunning, Tom E. Fletcher, Ewan R. Hunter, Michael Jacobs, Saye H. Khoo, William Newsholme, David Porter, Robert J. Porter, Libuse Ratcliffe, Matthias L. Schmid, Malcolm G. Semple, Anne J. Tunbridge, Tom Wingfield, Nicholas M. Price

Summary: This study retrospectively observed the clinical course of monkeypox in seven patients in the UK from 2018 to 2021. The study found that prolonged PCR positivity led to isolation of five patients for more than 3 weeks. Three patients treated with brincidofovir developed elevated liver enzymes, leading to termination of the therapy. One patient treated with tecovirimat experienced no adverse effects and had a shorter duration of viral shedding and illness compared to the other six patients.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

Alexander J. Mentzer, Daniel O'Connor, Sagida Bibi, Irina L. Chelysheva, Elizabeth A. Clutterbuck, Tesfaye Demissie, Tanya Dinesh, Nick M. Edwards, Sally Felle, Shuo C. Feng, Amy Flaxman, Eleanor Karp-Tatham, Grace Li, Xinxue J. Liu, Natalie Marchevsky, Leila Godfrey, Rebecca K. Makinson, Maireid O. Bull, Jamie N. Fowler, Bana Alamad, Tomas Malinauskas, Amanda Chong, Katherine Sanders, Robert Shaw, Merryn Voysey, Matthew D. Snape, Andrew J. Pollard, Teresa Lambe, Julian C. Knight

Summary: Variation in antibody levels elicited by the COVID-19 vaccine ChAdOx1 nCov-19 is linked to specific major histocompatibility complex class II alleles, providing insight into the breadth of immune response among vaccinated individuals. HLA-DQB1*06 allele is associated with higher levels of anti-RBD antibody and decreased risk of breakthrough infection. These findings have implications for future vaccine design and implementation.

NATURE MEDICINE (2023)

Add to Collection

Article Immunology

mRNA vaccination drives differential mucosal neutralizing antibody profiles in naive and SARS-CoV-2 previously-infected individuals

Stephanie Longet, Alexander Hargreaves, Saoirse Healy, Rebecca Brown, Hailey R. Hornsby, Naomi Meardon, Tom Tipton, Eleanor Barnes, Susanna Dunachie, Christopher J. A. Duncan, Paul Klenerman, Alex Richter, Lance Turtle, Thushan I. de Silva, Miles W. Carroll

Summary: Two doses of BNT162b2 mRNA vaccine induce a strong systemic humoral response to SARS-CoV-2, but mucosal immune response is important for defense against airborne transmission. This study characterizes the IgG responses to SARS-CoV-2 and other coronaviruses in oral fluid and plasma samples from UK healthcare workers. It also investigates the impact of previous infection and additional vaccine doses on the immune responses.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

Adrian M. Shields, Susan Tadros, Adam Al-Hakim, Jeremy M. Nell, Me Me Nay Lin, Michele Chan, Sarah Goddard, John Dempster, Magdalena Dziadzio, Smita Y. Patel, Shuayb Elkalifa, Aarnoud Huissoon, Christopher J. A. Duncan, Archana Herwadkar, Sujoy Khan, Claire Bethune, Suzanne Elcombe, James Thaventhiran, Paul Klenerman, David M. Lowe, Sinisa Savic, Siobhan O. Burns, Alex G. Richter

Summary: Individuals with primary and secondary immunodeficiency (PID/SID) have a higher risk of poor outcomes during the early stages of the SARS-CoV-2 pandemic. This study compared the outcomes of two cohorts of PID and SID patients, one infected prior to the availability of vaccination and treatments, and the other infected after these interventions became available. The results showed that vaccination, outpatient treatments, and the emergence of the B.1.1.529 variant have led to significant improvements in morbidity and mortality for PID patients. However, PID and SID patients still have a significantly increased risk of poor outcomes compared to the general population.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Correction Microbiology

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (vol 7, pg 1161, 2022)

Brian J. Willett, Joe Grove, Oscar A. MacLean, Craig Wilkie, Giuditta De Lorenzo, Wilhelm Furnon, Diego Cantoni, Sam Scott, Nicola Logan, Shirin Ashraf, Maria Manali, Agnieszka Szemiel, Vanessa Cowton, Elen Vink, William T. Harvey, Chris Davis, Patawee Asamaphan, Katherine Smollett, Lily Tong, Richard Orton, Joseph Hughes, Poppy Holland, Vanessa Silva, David J. Pascall, Kathryn Puxty, Ana da Silva Filipe, Gonzalo Yebra, Sharif Shaaban, Matthew T. G. Holden, Rute Maria Pinto, Rory Gunson, Kate Templeton, Pablo R. Murcia, Arvind H. Patel, Paul Klenerman, Susanna Dunachie, John Haughney, David L. Robertson, Massimo Palmarini, Surajit Ray, Emma C. Thomson

NATURE MICROBIOLOGY (2022)

Add to Collection

Article Infectious Diseases

Sensitivity and specificity of monocyte distribution width (MDW) in detecting patients with infection and sepsis in patients on sepsis pathway in the emergency department

Martina Cusinato, Narani Sivayoham, Timothy Planche

Summary: This study assessed the accuracy of monocyte distribution width (MDW) in patients with suspected sepsis. The results showed that MDW performed similarly to other commonly used biomarkers in identifying sepsis and could be a useful additional marker of infection.

INFECTION (2023)

Add to Collection

Article Infectious Diseases

Clinical features and management of individuals admitted to hospital with monkeypox and associated complications acrossthe UK: a retrospective cohort study

Douglas L. Fink, Helen Callaby, Akish Luintel, William Beynon, Helena Bond, Eleanor Y. Lim, Effrossyni Gkrania-Klotsas, Jospeh Heskin, Margherita Bracchi, Balram Rathish, Iain Milligan, Geraldine O'Hara, Stephanie Rimmer, Joanna R. Peters, Lara Payne, Nisha Mody, Bethany Hodgson, Penny Lewthwaite, Rebecca Lester, Stephen D. Woolley, Ann Sturdy, Ashley Whittington, Leann Johnson, Nathan Jacobs, John Quartey, Brendan A. Payne, Stewart Crowe, Ivo A. M. Elliott, Thomas Harrison, Joby Cole, Katie Beard, Tomas-Paul Cusack, Imogen Jones, Rishi Banerjee, Tommy Rampling, Jake Dunning

Summary: The 2022 global mpox outbreak has been unprecedented, with over 67,000 cases reported in non-endemic countries. Although mortality is rare, hospital admission is relatively common. This study found that males, white ethnicity, and HIV-infected patients were more likely to be hospitalized, and severe pain and secondary bacterial infection were the main reasons for admission.

LANCET INFECTIOUS DISEASES (2023)

Add to Collection

Article Infectious Diseases

Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of Clostridioides difficile Infection

Laura Whitney, John Nesnas, Timothy Planche

Summary: This study compared the cost-effectiveness and budget impact of fidaxomicin versus vancomycin or metronidazole for treating CDI. The findings demonstrate that fidaxomicin has lower recurrence rates and can reduce overall healthcare costs for CDI treatment.

ANTIBIOTICS-BASEL (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

S. Cotton, M. P. McHugh, R. Dewar, J. G. Haas, K. Templeton

Summary: This study investigated whether patients discharged from hospitals during the first wave of the SARS-CoV-2 epidemic in Scotland were a source of virus introduction into care homes. The majority of patients discharged did not introduce the virus into care homes, highlighting the importance of screening all new admissions when faced with a novel emerging virus and no available vaccine.

JOURNAL OF HOSPITAL INFECTION (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.